- What does ADNRX invest in?
- The Fund seeks long-term growth of capital. The Fund seeks to achieve its objective by investing primarily all of the Fund's assets in domestic and foreign equity securities including common stocks and other equity investments or ownership interests in business enterprises that are relevant to disruptive innovation.
- What is the expense ratio of ADNRX?
- American Beacon ARK Transformational Innovation Fd;R6 (ADNRX) charges an expense ratio of 1.05%. This is the annual fee deducted from fund assets to cover management and operations.
- How big is ADNRX?
- American Beacon ARK Transformational Innovation Fd;R6 (ADNRX) manages $181.3M in total assets. AUM determines bid-ask liquidity and the fund's vulnerability to closure — funds below ~$50M are at higher risk of liquidation.
- Is ADNRX actively managed or an index fund?
- ADNRX's management style is described in the fund's prospectus. See the description on the Summary tab for the published strategy.
- When was ADNRX launched?
- American Beacon ARK Transformational Innovation Fd;R6 (ADNRX) launched in October 2020 and is managed by the fund issuer.
- How has ADNRX performed?
- ADNRX's total return — price change plus reinvested distributions — is charted at the top of this page. Switch the price chart to Total Return and pick a 1-year, 3-year, 5-year, or 10-year window to read the compound annual growth rate (CAGR) over each horizon.
